Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NMN for Tinnitus
jRCTs041220129Recruiting
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in tinnitus comparing NMN arm with Placebo arm (2 arms). Primary endpoint: TRSw. Started Feb 2026; status: recruiting.
02
Drugs
nicotinamide mononucleotide
03
Conditions
tinnitus
Beyond the preview
Go deeper on jRCTs041220129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041220129.